http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990084844-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate | 1998-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1999-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19990084844-A |
| titleOfInvention | Sephachlor's sustained release matrix formulation |
| abstract | The present invention relates to a sustained-release matrix formulation of Sephachlor, and more particularly, containing Sephachlor as an active ingredient, which contains a hydrophilic polymer, β-cyclodextrin, a stabilizer, a disintegrant, an excipient, a lubricant, and the like. By formulating a drug into a sustained release formulation, the present invention relates to a sustained-release matrix formulation of Sephachlor, which improves the bioavailability by improving the stability of Sephachlor, which is pH-stable in the weakly intestinal intestine, and improving the bioavailability. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100965017-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040043589-A |
| priorityDate | 1998-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.